Analysis of Market Complaint Types Q1-Q4 2025

Q2 2025: Packaging Concerns Emerge

Q2 saw a significant shift, with Packaging complaints rising sharply to 11, becoming the highest category for the quarter. Quality complaints decreased to 4, suggesting that corrective actions for quality issues may have been effective, while highlighting packaging as a new area of risk. Q2 also had the highest overall complaint volume at 15.

Q3 & Q4 2025: Improvement and Stabilization

In Q3, overall complaints decreased to 12, with Packaging complaints at 8 and Quality complaints stable at 4, indicating some improvement in packaging controls. By Q4, total complaints further declined to 9, with both Quality and Packaging complaints equalized at 4 each. One isolated Medical complaint was reported in Q4. This trend demonstrates a consistent improvement and stabilization in the latter half of the year.

Annual Trend and Management Effectiveness

The annual trend shows a transition from quality issues early in 2025 to packaging challenges mid-year, followed by significant improvement and stabilization. The reduction in total complaints by Q4 suggests effective root cause analysis, implementation of corrective actions, and a strengthening of the quality management system. This indicates a maturing complaint-handling process and continuous improvement across various functions.

Q1 2025: Quality Issues Dominant

During the first quarter of 2025, Quality complaints were the primary concern, making up 9 of the 13 total complaints. Packaging issues were less frequent, accounting for 4 complaints, suggesting an early focus on product quality feedback.

Overview of 2025 Market Complaints

In 2025, a total of 49 market complaints were recorded. Packaging issues were the most frequent with 27 complaints, followed by Quality-related complaints with 21. Only one Medical complaint was reported, indicating that most concerns were operational rather than clinical or safety-related.